Insider Trading
Aurinia Pharmaceuticals Insider Bought Shares Worth $12,455,227, According to a Recent SEC Filing
Kevin Tang, 10% Owner, Director, Chief Executive Officer, on May 29, 2026, executed a purchase for 814,606 shares in Aurinia Pharmaceuticals (AUPH) for $12,455,227. Following the Form 4 filing with the SEC, Tang has control over a total of 13,044,106 common shares of the company, with 13,044,106 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1600620/000117857926000004/xslF345X05/form4-06032026_010631.xml
$AUPH
